Oncotelic Therapeutics OTLC
OTC OTLC
$0.02 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

Oncotelic Therapeutics (OTLC) Total Non-Current Liabilities (2010 - 2026)

Updated

Oncotelic Therapeutics (OTLC) posted Total Non-Current Liabilities of $127.56 million for Q2 2026, up 665.6% from $16.66 million a year earlier.

Analysis

Oncotelic Therapeutics (OTLC) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Oncotelic Therapeutics' Total Non-Current Liabilities came in at $129.33 million, up 599.2% from FY2024.

  • Annual Total Non-Current Liabilities shows a five-year compound annual growth rate of 72.0% (FY2020 to FY2025).
  • In prior years, Oncotelic Therapeutics' Total Non-Current Liabilities was $18.5 million in FY2024 (+874.3%), $1.9 million in FY2023 (-88.7%), $16.76 million in FY2022 (+30.4%) and $12.85 million in FY2021 (+49.8%).
  • Quarterly Total Non-Current Liabilities has run from a low of $1.9 million in Q4 2023 to a high of $129.33 million in Q4 2025 over five years.
  • On a year-over-year basis, Total Non-Current Liabilities increased in six of the last seven quarters, with growth averaging 477.2%.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q4 2024, with growth of 874.3%; the weakest was Q4 2023, with a decline of 88.7%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn 105.50 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn 106.45 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn 33.91 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn 35.10 Bn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn 97.04 Bn
10 Oncotelic Therapeutics 8.28 Mn 7.42 Mn - 127.56 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 127.56 Mn
Dec 31, 2025 129.33 Mn
Sep 30, 2025 16.48 Mn
Jun 30, 2025 16.66 Mn
Mar 31, 2025 16.86 Mn
Dec 31, 2024 18.50 Mn
Sep 30, 2024 2.29 Mn
Jun 30, 2024 15.81 Mn
Mar 31, 2024 2.21 Mn
Dec 31, 2023 1.90 Mn
Sep 30, 2023 15.39 Mn
Jun 30, 2023 15.46 Mn
Mar 31, 2023 14.97 Mn
Dec 31, 2022 16.76 Mn
Sep 30, 2022 13.59 Mn
Jun 30, 2022 13.48 Mn
Mar 31, 2022 14.21 Mn
Dec 31, 2021 12.85 Mn
Sep 30, 2021 12.20 Mn
Jun 30, 2021 11.53 Mn
API Access

Oncotelic Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=OTLC&period=max&api_key=YOUR_API_KEY